GNAS and pancreatic intraductal papillary-mucinous neoplasm: They found that GNAS in ctDNA from peripheral blood of patients with pancreatic cysts was significantly higher in those with IPMN so this mutation can serve as a specific IPMN predictor for differentiating it from the various PCNs.